Efficacy and tolerability of oral oxycodone and oxycodone/naloxone combination in opioid-naïve cancer patients: a propensity analysis

BACKGROUND: World Health Organization step III opioids are required to relieve moderate-to-severe cancer pain; constipation is one of the most frequent opioid-induced side effects. A fixed combination, prolonged-release oxycodone/naloxone (OXN), was developed with the aim of reducing opioid-related...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazzari, Marzia, Greco, Maria Teresa, Marcassa, Claudio, Finocchi, Simona, Caldarulo, Clarissa, Corli, Oscar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636087/
https://www.ncbi.nlm.nih.gov/pubmed/26586937
http://dx.doi.org/10.2147/DDDT.S92998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4636087/
https://www.ncbi.nlm.nih.gov/pubmed/26586937
http://dx.doi.org/10.2147/DDDT.S92998

Ejemplares similares